Evoke Pharma Inc. (EVOK)

AI Score

Unlock

2.46

0.13 (5.62%)

At close: Apr 22, 2025, 3:59 PM

2.40

-2.44%

After-hours: Apr 22, 2025, 06:22 PM EDT

Evoke Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-1.19M	-1.31M	-1.27M	-1.58M	-1.99M	-1.69M	-1.87M	-2.24M	-1.8M	-2.01M	-2.23M	-2.17M	-1.67M	-1.97M	-2.29M	-2.61M	-2.27M	-2.13M	-6.97M	-1.79M	-1.42M	-1.63M	-2.11M	-1.97M	-1.76M	-1.52M	-2.3M	-1.98M	-308.44K	-5.24M	-1.63M	-5.05M	-1.53M	-3.03M	-2.97M	-3.23M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	260.93K	131.59K	126.58K	254.03K	281.64K	281.76K	280.14K	284.57K	354.97K	355.75K	366.92K	381.06K	454.2K	464K	399.41K	561.35K	476.87K	478.57K	362.95K	310.16K	318.86K	331.3K	344.84K	378.96K	378.2K	380.06K	387.43K	393.77K	414.5K	475.9K	464.87K	464.16K	408.25K	452.24K	427.13K	418.91K
Other Working Capital	-451.08K	1.34M	459.83K	-836.08K	25.92K	216.74K	212.68K	100.78K	-942.59K	188.33K	559.48K	243.27K	-714.16K	189.31K	183.64K	-455.81K	4.45M	-193.58K	228.04K	227.09K	229.3K	-631.47K	143.2K	142.3K	918.64K	-355.27K	83.68K	83.68K	-1.15M	253.2K	-416.41K	104.18K	822.73K	74.08K	265.4K	68.56K
Other Non-Cash Items	142.71K	-820.78K	515.7K	920.86K	13.37K	39.47K	38.56K	37.68K	24.6K	221.06K	433.65K	446.76K	30K	518.06K	-962	-104.17K	-5.05M	53.44K	5M	-140.94K	-277.62K	869.14K	-2.37K	-482.88K	23.78K	344.74K	70.34K	-433.39K	-2.35M	1.54M	-1.26M	3.07M	-796.56K	832.8K	10.36K	10.36K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-450.92K	1.18M	195.37K	-1.38M	586.29K	331.07K	342.85K	289.93K	-1.08M	544.76K	492.75K	177.57K	-809.04K	-4.39M	381.7K	-804.8K	5.13M	-213.44K	48.36K	-71.75K	-48.32K	237.67K	140.83K	-340.58K	133.51K	-10.53K	154.02K	-795.56K	-490.14K	1.02M	326.79K	-171.68K	546.01K	-677.73K	303.08K	105.93K
Operating Cash Flow	-1.24M	-818.7K	-820.62K	-2.58M	-1.11M	-1.04M	-1.21M	-1.63M	-2.51M	-1.1M	-1.37M	-1.62M	-2M	-5.89M	-1.51M	-2.95M	-1.71M	-1.81M	-1.56M	-1.55M	-1.15M	-1.06M	-1.63M	-1.93M	-1.25M	-1.15M	-1.76M	-2.82M	-2.73M	-2.2M	-2.1M	-1.69M	-1.37M	-2.42M	-2.23M	-2.69M
Capital Expenditures	n/a	5.00	-5	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.71M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.5K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.5M	2.98M	295.7K	824.51K	-119.3K	n/a	n/a	n/a	-148.99K	148.99K	-148.99K	n/a	313.11K	n/a	-1.26M	n/a	213.19K	100.79K	5.41M	21.25K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-54.36K	n/a	n/a	n/a	n/a	-4.5M	n/a	n/a
Financial Cash Flow	3.5M	2.98M	295.7K	7.54M	-119.3K	n/a	n/a	n/a	7.29K	n/a	7.12M	171.52K	n/a	313.11K	45.45K	13.07M	3.5M	100.79K	5.41M	21.25K	306.72K	123.81K	5.04M	636.43K	n/a	1.19M	2.89M	544.64K	n/a	56.86K	-2.5K	7.33M	-3.17K	8.67M	259.28K	98.74K
Net Cash Flow	2.26M	2.16M	-524.92K	4.96M	-1.23M	-1.04M	-1.21M	-1.63M	-2.51M	-1.1M	5.75M	-1.44M	-2M	-5.58M	-1.47M	10.12M	1.79M	-1.71M	3.86M	-1.53M	-840.97K	-935.28K	3.41M	-1.29M	-1.25M	36.84K	1.13M	-2.27M	-2.73M	-2.14M	-2.1M	5.65M	-1.37M	6.25M	-1.97M	-2.59M
Free Cash Flow	-1.24M	-818.69K	-820.62K	-2.58M	-1.11M	-1.04M	-1.21M	-1.63M	-2.51M	-1.1M	-1.37M	-1.62M	-2M	-5.89M	-1.51M	-2.95M	-1.71M	-1.81M	-1.56M	-1.55M	-1.15M	-1.06M	-1.63M	-1.93M	-1.25M	-1.15M	-1.76M	-2.82M	-2.73M	-2.2M	-2.1M	-1.69M	-1.37M	-2.42M	-2.23M	-2.69M